Putra Mandiri Jembar Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Putra Mandiri Jembar Tbk. trades at Rp113 (market cap 1.53T, 78.2K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,620 (market cap 11.64T, 5.1K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 7.6× Putra Mandiri Jembar Tbk.'s market cap, and Putra Mandiri Jembar Tbk. is more actively traded (78.2K versus 5.1K). Which is the better fit depends on your goals.
| PMJS | TSPC | |
|---|---|---|
Market Cap | 1.53T | 11.64T |
Volume | 78.2K | 5.1K |
Lot | 782 | 51 |
Turnover | 8.73M | 13.27M |
Average Price | 111.63 | 2,601.96 |
Value | 8.73M | 13.27M |
Indicative Equilibrium Price | 111 | 2,600 |
Indicative Equilibrium Volume | 31.2K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Putra Mandiri Jembar Tbk (the Company) was domiciled in Jakarta, established under the Deed No. 52 dated 18 July 2003 by notary Arikanti Natakusumah, S.H. PT Pahalamas Sejahtera is the parent entity and ultimate holding of the Company.
Read more on PMJS →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →